Dr. Reyblat offers advice for urologists who want to provide for more transgender and non-binary patients
“I think it's important to look at our practice from the consumer standpoint and see what we look like to our patients,” says Polina X. Reyblat, MD.
In this video, Polina X. Reyblat, MD, discusses ways in which urologists can attract minority genders to their practice and resources they can use to educate themselves and their staff. These ideas stem from Reyblat’s presentation, “Care for the transgender and non-binary patient – Role of the FPMRS caregiver,” which was given at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2022 Winter Meeting. Reyblat is a reconstructive urologist and the chief of the department of urology at the Kaiser Permanente Los Angeles Medical Center in Los Angeles, California.
Dr. Lacouture on managing dermatological adverse events with apalutamide in prostate cancer
February 7th 2022To investigate the severity and prevalence of dermatologic adverse events associated with apalutamide, Mario E. Lacouture, MD, and investigators conducted a study that will help to manage and counsel patients with prostate cancer in the future, especially with the expanded approval of apalutamide in this space.
How appropriate use criteria for PSMA-PET imaging optimize patient care
February 2nd 2022In a recent interview, Hossein Jadvar, MD, PhD, discussed what the appropriate use criteria consist of for prostate-specific membrane antigen (PSMA)-PET imaging, and why these criteria are vital in ensuring the individualized care of patients.
Dr. Padmanabhan discusses impact of COVID-19
June 11th 2020Urology Times® Editorial Council Member Priya Padmanabhan, MD, MPH, professor of urology at Oakland University William Beaumont School of Medicine, Royal Oak, Michigan, discusses how she has been affected by the coronavirus disease 2019 (COVID-19) pandemic.
